Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > 88% demonstrate that CR at 180 days, 69% at 270 days

<< Previous

Bullboard Posts

Next >>

Comment by Legit62on May 31, 2022 6:01am

227 Views

Post# 34719106

RE:RE:RE:RE:RE:RE:RE:RE:88% demonstrate that CR at 180 days, 69% at 270 days

Would have to agree, better data numbers as we move on, once all data is actualy finalized with proper dosing and certain patients removed due to unforseen events not related to trials, we get our BTD,AA and off we go. Still feel we have something in works now before all this breaks out,IMO, We are too good for this not to be happening, as i said before , stay patient longs cause we are real close. Our treatments safe, few treatments and very effective, going to be first option treatment, plus Covid vaccine most likely before end of year

<< Previous

Bullboard Posts

Next >>

Pro Women’s Hockey League comes to NHL 25 in December